• Can You Read These Rxs?
  • FDA Approves AstraZeneca’s Movantik for Opioid-Induced Constipation
  • Fall Allergies: The Pharmacist’s Role in Allergic Rhinitis Symptom Management and Patient Counseling
  • Sickle Cell Disease: Managing the Pain
  • Hydrocodone Combination Products: Moving from CIII to CII

Breaking News

The Age of Targeted Osteoarthritis Therapy Begins
Alpha-2-macroglobulin may soon revolutionize the treatment of osteoarthritis.
Thousands of US military personnel will deploy to West Africa.
Using a less market-oriented payment scheme could reduce high hospital administrative costs.
In a Phase 3 study, odanacatib significantly reduced the risk of osteoporotic fractures, but it also might have contributed to major cardiovascular events.
The respiratory virus that hospitalized hundreds of children in the Midwest and the South has now reached the Northeast.
Researchers found that inhibiting development of T helper 2 cells may be advantageous in the control of allergic responses.
Only 30% of the most commonly used mHealth apps have privacy policies.

From the Issue

$AD300x250BB$
Previous TabNext Tab
Strategic Alliance Partners
Latest Issues
$auto_registration$